Cargando…
Metabolomic profiling reveals amino acid and carnitine alterations as metabolic signatures in psoriasis
High-throughput metabolite profiling provides the opportunity to reveal metabolic mechanisms and identify biomarkers. Psoriasis is an immune-mediated chronic inflammatory disease. However, the role of metabolism in psoriasis pathogenesis remains unclear. Methods: Plasma samples of individuals (45 ps...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738860/ https://www.ncbi.nlm.nih.gov/pubmed/33391503 http://dx.doi.org/10.7150/thno.51154 |
_version_ | 1783623212028919808 |
---|---|
author | Chen, Chao Hou, Guixue Zeng, Chunwei Ren, Yan Chen, Xiang Peng, Cong |
author_facet | Chen, Chao Hou, Guixue Zeng, Chunwei Ren, Yan Chen, Xiang Peng, Cong |
author_sort | Chen, Chao |
collection | PubMed |
description | High-throughput metabolite profiling provides the opportunity to reveal metabolic mechanisms and identify biomarkers. Psoriasis is an immune-mediated chronic inflammatory disease. However, the role of metabolism in psoriasis pathogenesis remains unclear. Methods: Plasma samples of individuals (45 psoriasis and 45 sex‐, age-, and BMI-matched healthy controls) were collected. Non-targeted metabolomics and amino acid- or carnitine-targeted metabolomics were conducted, then, plasma samples of mice induced by imiquimod (IMQ) were subjected to the amino acid- and carnitine-targeted metabolomic profiling. Flow cytometry was used to study the effect of L-carnitine (LC(C0)) on IMQ-induced psoriatic inflammation. Results: Through the non-targeted metabolomics approach, we detected significantly altered amino acids and carnitines in psoriasis patients. Amino acid-targeted metabolomic profiling identified 37 amino acids altered in psoriasis, of these 23 were markedly upregulated, including essential amino acids (EAAs), and branched-chain amino acids (BCAAs), whereas glutamine, cysteine, and asparagine were significantly down-regulated. Carnitine-targeted metabolomic profiling identified 40 significantly altered carnitines, 14 of which included palmitoylcarnitine (C16) and were markedly downregulated in psoriasis, whereas hexanoylcarnitine (C6) and 3-OH-octadecenoylcarnitine (C18:1-OH) were significantly upregulated. Interestingly, glutamine, asparagine, and C16 levels were negatively correlated with the PASI score. Moreover, a higher abundance of LC(C0) was associated with markedly reduced IMQ-induced epidermal thickening and infiltration of Th17 cells in skin lesions, indicating LC(C0) supplementation as a potential therapy for psoriasis treatment. Conclusion: Our results suggested the metabolism of amino acids and carnitines are significantly altered in psoriasis, especially the metabolism of EAAs, BCAAs, and LC(C0), which may play key roles in the pathogenesis of psoriasis. |
format | Online Article Text |
id | pubmed-7738860 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-77388602021-01-01 Metabolomic profiling reveals amino acid and carnitine alterations as metabolic signatures in psoriasis Chen, Chao Hou, Guixue Zeng, Chunwei Ren, Yan Chen, Xiang Peng, Cong Theranostics Research Paper High-throughput metabolite profiling provides the opportunity to reveal metabolic mechanisms and identify biomarkers. Psoriasis is an immune-mediated chronic inflammatory disease. However, the role of metabolism in psoriasis pathogenesis remains unclear. Methods: Plasma samples of individuals (45 psoriasis and 45 sex‐, age-, and BMI-matched healthy controls) were collected. Non-targeted metabolomics and amino acid- or carnitine-targeted metabolomics were conducted, then, plasma samples of mice induced by imiquimod (IMQ) were subjected to the amino acid- and carnitine-targeted metabolomic profiling. Flow cytometry was used to study the effect of L-carnitine (LC(C0)) on IMQ-induced psoriatic inflammation. Results: Through the non-targeted metabolomics approach, we detected significantly altered amino acids and carnitines in psoriasis patients. Amino acid-targeted metabolomic profiling identified 37 amino acids altered in psoriasis, of these 23 were markedly upregulated, including essential amino acids (EAAs), and branched-chain amino acids (BCAAs), whereas glutamine, cysteine, and asparagine were significantly down-regulated. Carnitine-targeted metabolomic profiling identified 40 significantly altered carnitines, 14 of which included palmitoylcarnitine (C16) and were markedly downregulated in psoriasis, whereas hexanoylcarnitine (C6) and 3-OH-octadecenoylcarnitine (C18:1-OH) were significantly upregulated. Interestingly, glutamine, asparagine, and C16 levels were negatively correlated with the PASI score. Moreover, a higher abundance of LC(C0) was associated with markedly reduced IMQ-induced epidermal thickening and infiltration of Th17 cells in skin lesions, indicating LC(C0) supplementation as a potential therapy for psoriasis treatment. Conclusion: Our results suggested the metabolism of amino acids and carnitines are significantly altered in psoriasis, especially the metabolism of EAAs, BCAAs, and LC(C0), which may play key roles in the pathogenesis of psoriasis. Ivyspring International Publisher 2021-01-01 /pmc/articles/PMC7738860/ /pubmed/33391503 http://dx.doi.org/10.7150/thno.51154 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Research Paper Chen, Chao Hou, Guixue Zeng, Chunwei Ren, Yan Chen, Xiang Peng, Cong Metabolomic profiling reveals amino acid and carnitine alterations as metabolic signatures in psoriasis |
title | Metabolomic profiling reveals amino acid and carnitine alterations as metabolic signatures in psoriasis |
title_full | Metabolomic profiling reveals amino acid and carnitine alterations as metabolic signatures in psoriasis |
title_fullStr | Metabolomic profiling reveals amino acid and carnitine alterations as metabolic signatures in psoriasis |
title_full_unstemmed | Metabolomic profiling reveals amino acid and carnitine alterations as metabolic signatures in psoriasis |
title_short | Metabolomic profiling reveals amino acid and carnitine alterations as metabolic signatures in psoriasis |
title_sort | metabolomic profiling reveals amino acid and carnitine alterations as metabolic signatures in psoriasis |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738860/ https://www.ncbi.nlm.nih.gov/pubmed/33391503 http://dx.doi.org/10.7150/thno.51154 |
work_keys_str_mv | AT chenchao metabolomicprofilingrevealsaminoacidandcarnitinealterationsasmetabolicsignaturesinpsoriasis AT houguixue metabolomicprofilingrevealsaminoacidandcarnitinealterationsasmetabolicsignaturesinpsoriasis AT zengchunwei metabolomicprofilingrevealsaminoacidandcarnitinealterationsasmetabolicsignaturesinpsoriasis AT renyan metabolomicprofilingrevealsaminoacidandcarnitinealterationsasmetabolicsignaturesinpsoriasis AT chenxiang metabolomicprofilingrevealsaminoacidandcarnitinealterationsasmetabolicsignaturesinpsoriasis AT pengcong metabolomicprofilingrevealsaminoacidandcarnitinealterationsasmetabolicsignaturesinpsoriasis |